

















































便潜血 (十) Na 138mEq/1 
Hb 12.3g/dl K 3.7mEq/1 
WBC 19910/μ| CI 102mEq/1 
neut 86.8% BUN 12mg/dl 
Iy 4.9% Cr 0.7mg/dl 
打10 8.1% UA 3.5mg/dl 
eo 0.1% 
ba 0.1% GOT 1 IU/I 
Plt 28.3X104/μ| GPT 81U/1 
PT 15.5sec LDH 2111U/1 
APTT 48.6sec T-bil 0.4 mg/dl 
Fib 563mg/dl 
AT-皿 61% CRP 30.6mg/dl 
FDP 5μg/ml HLA-B51 (+) 
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mesalazine 1500mg/day 








CRP (mg/dl) 30.6 16.6 0.9 
便行 10r ¥¥，--¥ 
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Intestinal Behcet Disease Treated Effectively by Mesalazine 
Tomoko HARA， Tetsuya GOTO， Satoshi KIMURA 
Koichi SATO， Osamu FUJINO， Junichi NAGATA 
Division of Internal Medicine， Komatushima Red Cross Hospital 
A 30-year-old women with Behcet disease was referred to our department because of fever and watery 
diarrhea started from the end of May， 1998. The patient had chronic recurrent oral aphtha， foliculitis， 
nodular erythema and ulceration of vulva indicating incomplete type of Behcet disease and these 
symptoms had been controlled wel by the administration of predonisolone at 2.5 mg/day. Although the 
symptoms subsided by fasting， fluid therapy and administration of antibiotics， colonoscopy revealed 
m ultiple occurrence of punching ulcers and aph thous巴rosionsin the proximal colon and the rectum. 
Based on these findings， a diagnosis of intestinal Behc巴tdisease was made. Administration of mesalazine 
at 1.5 g/day relieved not only gastrointestinal symptoms but also joint pain and skin symptoms and 
steroid was also withdrawn. There was no subsequent recurrence as an outpatient and colonoscopy after 
7 months showed distinct improvement of the mucosallesions. 
Mesalazine was considered as therapeutic which should be tried for intestinal Behc巴tdisease though the 
mechanism of its action remains to be elucidated 
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